MspA1 polymorphism of the CYP17 gene in breast cysts

References

• Menezes Jr. DMA. Afecções Benignas da Mama. J Bras Ginec 1988;98:339–347.
   Google Scholar
• Houssami N, Cheung MN, Dixon JM. Fibroadenoma of the breast. Med J Aust 2001;174:185–188.
   PubMed Web of Science ®Google Scholar
• Budai B, Szamel I, Sulyok Z, Nemeth M, Bak M, Kralovansky J, Otto SZ, et al. Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk. Anticancer Res 2000;20:3879–3886.
   PubMed Web of Science ®Google Scholar
• Haagensen CD. Diseases of the breast. 2nd ed. Philadelphia: W. B. Saunders; 1971.
   Google Scholar
• Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V, Kuttenn F, et al. Benign breast diseases. J Mammary Gland Biol Neoplasia 2005;10:325–335.
   PubMed Web of Science ®Google Scholar
• Nazário ACP, de Lima GR, Simões MJ, Novo NF. Cell kinetics of the human mammary lobule during the proliferative and secretory phase of the menstrual cycle. Bull Assoc Anat 1995;79: 23–27.
   PubMedGoogle Scholar
• Dixon JM, Scott WN, Miller WR. An analysis of the content and morphology of human breast macrocysts. Eur J Surg Oncol 1985;11:151–154.
   PubMedGoogle Scholar
• Dupont WD, Page DL. Risk factor for breast cancer in women with proliferative breast disease. N Eng J Med 1985;312:146–151.
   PubMed Web of Science ®Google Scholar
• Uriburu JV, Uriburu JL. Fisiopatologia y tratamiento de la displasia mamaria ciclica. Bol A N Med Buenos Aires 1991;69:513–533.
   Google Scholar
• Ferguson DJP, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast. Br J Cancer 1981;44:177–181.
   PubMed Web of Science ®Google Scholar
• Going JJ, Anderson TJ, Battersby S, Macintyre CCA. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 1988;130:193–204.
   PubMed Web of Science ®Google Scholar
• Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003;544:9–41.
   PubMed Web of Science ®Google Scholar
• Kado N, Kitawake J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 2002;17:897–902.
   PubMed Web of Science ®Google Scholar
• Huber JC, Schneeberger C, Tempfer CB. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 2002;42:1–12.
   PubMed Web of Science ®Google Scholar
• Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997;57:1063–1065.
   PubMed Web of Science ®Google Scholar
• Feigelson HS, Mckean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM. Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use a hormone replacement therapy. Cancer Res 1999;59:3908–3910.
   PubMed Web of Science ®Google Scholar
• Travis RC, Churchman M, Edwards SA, Smith G, Verkasalo PK, Wolf CR, Wolf H, Key TJ. No association of polymorphism in CYP17, CYP19 and HSD17-B1 with plasma estradiol concentrations in 1,090 British women. Cancer Epidemiol Biomakers Prev 2004;13:2282–2284.
   PubMed Web of Science ®Google Scholar
• Tworoger SS, Chubak J, Allelo EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomakers Prev 2004;13:94–101.
   PubMed Web of Science ®Google Scholar
• Ahsan H, Whittemore AS, Chen Y, Senie RT, Hamilton SP, Wang Q, Gurvich I, Santella RM. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk, a family-based genetic association study. Breast Cancer Res 2005;7:871–881.
   Web of Science ®Google Scholar
• Torresan C, Oliveira MMC, Torrezan GT, De Oliveira SF, Abuazar CS, Losi-Guembarovski R, Lima RS, et al. Genetic polymorphism in oestrogen metabolic pathway and breast cancer; a positive association with combined CYP/GST genotypes. Clin Exp Med 2008;8:65–71.
   PubMed Web of Science ®Google Scholar
• Sakoda CL, Blackston C, Doherty JA, Ray RM, Lin MG, Stalsberg H, Gao DL, et al. Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer Epidemiol Biomarkers Prev 2008;17:1066–1073.
   PubMed Web of Science ®Google Scholar
• Murillo Ortiz B, Botello Hernandes D, Ramires Mateos C, Reynaga Garcia FJ. Benign breast diseases: clinical, radiological and pathological correlation. Ginecol Obstet Mex 2002;70:613–618.
   PubMedGoogle Scholar
• Gateley CA, Bundred NJ, West RR, Mansel RE. A case control study of factors associated with macroscopic breast cysts. Eur J Cancer 1992;28:125–127.
   PubMedGoogle Scholar
• Leon LG, Rodriguez EP. Displasia mamária. Estudio de 100 casos. Rev Cub Obst Ginec 1983;9:161–165.
   Google Scholar
• Tserotas K, Villota CM. Trastornos fibroquísticos de la mama. Ginec Obst Mex 1998;66:362–366.
   PubMedGoogle Scholar
• Hughes LE, Bundred NJ. Breast macrocysts. World J Surg 1989;13:711–714.
   PubMed Web of Science ®Google Scholar
• Houssami N, Irwig L, Ung O. Review of complex breast cysts: implication for cancer detection and clinical practice. ANZ J Surg 2005;75:1080–1085.
   PubMed Web of Science ®Google Scholar
• Marchant DJ. Benign Breast Disease - Fibrocystic changes. Rev Ginecol Obstet 1994;5:109–118.
   Google Scholar